Wasatch Advisors’s Esperion Therapeutics ESPR Stock Holding History

Wasatch Advisors’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.1M	Sell	1,930,185 -13,838,712	-88%	-$38.7M	0.04%	167
2026 Q1	$43.2M	Buy	15,768,897 +6,323,138	+67%	+$20M	0.29%	85
2025 Q4	$34.9M	Buy	9,445,759 +2,383,902	+34%	+$7.7M	0.21%	97
2025 Q3	$18.7M	Sell	7,061,857 -3,278,404	-32%	-$6.34M	0.1%	129
2025 Q2	$10.2M	Sell	10,340,261 -590,996	-5%	-$592K	0.05%	157
2025 Q1	$15.7M	Sell	10,931,257 -13,551,001	-55%	-$25M	0.09%	137
2024 Q4	$53.9M	Buy	24,482,258 +1,136,245	+5%	+$2.65M	0.27%	93
2024 Q3	$38.5M	Buy	23,346,013 +6,483,070	+38%	+$13.1M	0.19%	106
2024 Q2	$37.4M	Buy	16,862,943 +7,733,296	+85%	+$18.2M	0.2%	106
2024 Q1	$24.5M	Buy	9,129,647 +238,544	+3%	+$580K	0.13%	124
2023 Q4	$26.6M	Sell	8,891,103 -2,634,997	-23%	-$3.42M	0.15%	115
2023 Q3	$11.3M	Sell	11,526,100 -1,613,456	-12%	-$2.33M	0.07%	139
2023 Q2	$18.3M	Sell	13,139,556 -214,630	-2%	-$300K	0.11%	133
2023 Q1	$21.2M	Buy	13,354,186 +6,505,808	+95%	+$33.6M	0.13%	131
2022 Q4	$42.7M	Sell	6,848,378 -614,638	-8%	-$4.4M	0.29%	83
2022 Q3	$50M	Sell	7,463,016 -82,992	-1%	-$570K	0.35%	78
2022 Q2	$48M	Sell	7,546,008 -601,372	-7%	-$3.41M	0.3%	89
2022 Q1	$37.8M	Buy	8,147,380 +1,761,117	+28%	+$7.55M	0.19%	109
2021 Q4	$31.9M	Buy	6,386,263 +3,111,903	+95%	+$24.9M	0.13%	139
2021 Q3	$39.5M	Sell	3,274,360 -492,575	-13%	-$7.17M	0.16%	130
2021 Q2	$79.7M	Sell	3,766,935 -351,150	-9%	-$8.46M	0.32%	88
2021 Q1	$116M	Buy	4,118,085 +120,075	+3%	+$3.54M	0.52%	68
2020 Q4	$104M	Buy	3,998,010 +1,588,327	+66%	+$47.6M	0.51%	69
2020 Q3	$89.6M	Buy	2,409,683 +1,165,257	+94%	+$46.2M	0.57%	59
2020 Q2	$63.9M	Buy	1,244,426 +338,090	+37%	+$14.1M	0.46%	74
2020 Q1	$28.6M	Buy	906,336 +241,629	+36%	+$12.8M	0.3%	78
2019 Q4	$39.6M	Buy	664,707 +34,310	+5%	+$1.54M	0.33%	84
2019 Q3	$23.1M	Sell	630,397 -7,978	-1%	-$316K	0.22%	97
2019 Q2	$29.7M	Buy	638,375 +586	+0.1%	+$27.5K	0.29%	83
2019 Q1	$25.6M	Buy	637,789 +75,165	+13%	+$3.37M	0.28%	80
2018 Q4	$25.9M	Buy	562,624 +5,339	+1%	+$257K	0.35%	74
2018 Q3	$24.7M	Buy	557,285 +16,273	+3%	+$747K	0.28%	78
2018 Q2	$21.2M	Sell	541,012 -50,230	-8%	-$2.54M	0.26%	80
2018 Q1	$42.8M	Sell	591,242 -102,023	-15%	-$7.49M	0.55%	62
2017 Q4	$45.6M	Sell	693,265 -20,139	-3%	-$1.08M	0.61%	61
2017 Q3	$35.8M	Sell	713,404 -42,311	-6%	-$2.04M	0.49%	69
2017 Q2	$35M	Sell	755,715 -10,828	-1%	-$398K	0.49%	64
2017 Q1	$27.1M	Buy	766,543 +228,349	+42%	+$5.23M	0.4%	73
2016 Q4	$6.74M	Buy	538,194 +11,477	+2%	+$137K	0.1%	149
2016 Q3	$7.29M	Sell	526,717 -7,057	-1%	-$80K	0.11%	157
2016 Q2	$5.27M	Sell	533,774 -225,409	-30%	-$3.74M	0.08%	200
2016 Q1	$12.5M	Buy	759,183 +43,602	+6%	+$701K	0.19%	125
2015 Q4	$15.9M	Buy	715,581 +25,208	+4%	+$636K	0.22%	120
2015 Q3	$16.3M	Sell	690,373 -12,960	-2%	-$813K	0.22%	131
2015 Q2	$57.5M	Sell	703,333 -52,238	-7%	-$5.11M	0.63%	51
2015 Q1	$70M	Sell	755,571 -247,151	-25%	-$15.9M	0.73%	39
2014 Q4	$40.5M	Buy	1,002,722 +418,688	+72%	+$12.8M	0.42%	89
2014 Q3	$14.3M	Sell	584,034 -19,997	-3%	-$318K	0.15%	152
2014 Q2	$9.57M	Sell	604,031 -2,533	-0.4%	-$36.6K	0.09%	208
2014 Q1	$9.17M	Sell	606,564 -13,260	-2%	-$206K	0.09%	207
2013 Q4	$8.52M	Buy	619,824 +189,529	+44%	+$2.76M	0.08%	204
2013 Q3	$8.12M	Buy	430,295 +9,842	+2%	+$165K	0.08%	207
2013 Q2	$5.93M	Buy	+420,453	New	+$5.97M	0.07%	238

Other funds holding ESPR

Eleva Capital Paris, France $343M AUM

FIA

FNY Investment Advisers New York $277M AUM 98.95% 1-Year Est. Return

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.6B AUM 29.42% 1-Year Est. Return

ACA

Affinity Capital Advisors Berkeley, California $810M AUM 24.85% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

CSB

City State Bank Norwalk, Iowa $436M AUM 32.32% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return